Key facts
- This page summarizes Chak Hua Yew's Form 3 filing for CytoMed Therapeutics Ltd (GDTC).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 May 2026, 09:00.
Chak Hua Yew - 18 Mar 2026 Form 3 Insider Report for CytoMed Therapeutics Ltd (GDTC)
- Reporting relationship
- Director
- Issuer ticker
- GDTC
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 15 May 2026, 09:00:36 UTC
- Prior SEC filing
- 04 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Chak Hua Yew
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Chak Hua Yew filed Form 3 for CytoMed Therapeutics Ltd (GDTC) on 15 May 2026.
Change
- Previous filing in this sequence was filed on 04 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001973390
Primary reporting owner
Yew Chak Hua
- Relationship
- Director
- Address
- C/O CYTOMED THERAPEUTICS LIMITED, 1 COMMONWEALTH LANE #08-22, SINGAPORE, SINGAPORE
- Signature
- /s/ Chak Hua Yew
- Signature date
- 15 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GDTC
holding
Ordinary Shares, no par value per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,469
- Date
- 18 Mar 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.